The competition authority issues its decision on the merger of Mehiläinen and Docrates Cancer Center
By Lotta Mitro
– We are pleased that the Docrates acquisition will be completed and enables us to offer a more comprehensive service to our customers when it comes to cancer. The acquisition expands our services also internationally. As a pioneer in cancer treatments, Docrates has built a unique treatment path that is sought after by customers from … Continued